Uncategorized

                                                                                                  Statement on release of Release of Health Canada Final Report of the Expert Panel on Immune Globulin CIPO welcomes the panel’s...

Click on the link below for the full report: Protecting IG for Canadians

Details of the IPOPI position statement regarding access to immunoglobulin therapies for patients living with a primary immunodeficiency can be found here: IPOPI-2018-Position-Statement

IPOPI are seeking the input of patients living with primary immunodeficiency and parents who are taking care of a child with a primary immunodeficiency (under the age of 18 years), using IG replacement therapy who have switched...

Safety, Acceptance, Fairness, and Equality (SAFE Project): Acceptable Risk and Donor Selection This study, conducted by researchers at McGill University and the University of Nottingham (funded by the Canadian Blood Services),...

April 10th, 2018 Update on Immune Globulin Products in Canada Dear CIPO member, Since late 2017 we have been updating our membership in regards to changes to certain immune globulin products. We know that some of you have voiced...

March 8th, 2018   Update on Immune Globulin Products in Canada   Dear CIPO member, Over the last few months, we have sent three letters updating you about changes that are taking place across Canada in regards to certain...

February 1st, 2018   Update on Immune Globulin Products in Canada   Dear CIPO member, On November 2nd and December 19th, we sent letters updating you about changes that are taking place across Canada in regards to certain...